Association of albuminuria with impaired aortic elasticity and left ventricular diastolic dysfunction in type 2 diabetes

Anadolu Kardiyoloji Dergisi

Volumn 8, Issue 1, 2008, Pages 10-15

  Duman, Dursun ^a   Demirtunç, Refik ^a   Karadag, Bilgehan ^b   Karataş, Meryem ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Albuminuria; Aortic stiffness; Diabetes mellitus; Left ventricular diastolic function

Indexed keywords

ALBUMIN; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ALBUMINURIA; ANALYSIS OF VARIANCE; AORTA DISEASE; AORTA ROOT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE RELAXATION; HEART LEFT VENTRICLE SIZE; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; TRANSTHORACIC ECHOCARDIOGRAPHY;

ALBUMINURIA; AORTA, THORACIC; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; LASER-DOPPLER FLOWMETRY; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; VASODILATION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 39449094908     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-9.
2. Castelli WP: Lipids, risk factors and ischemic heart disease. Atherosclerosis 1996; 124 Suppl: S1-S9.
3. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. HOPE Study Investigators: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421-6.
4. de Zeeuw D, Remuzzi G, Parving H-H, Keane WF, Zhang Z, Shahinfar S, et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 2004; 110: 921-7.
5. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997; 157: 1413-8.
6. Mogensen CE. Microalbuminuria, blood pressure and diabetic renal disease: Origin and development of ideas. Diabetologia 1999; 42: 263-85.
7. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32: 219-26.
8. Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992; 340: 319-23.
9. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: An integrated index of vascular function? Circulation 2002; 106: 2085-90.
10. Morgensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310: 356-60.
11. Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992; 42: 736-41.
12. Mattock MB, Barnes DJ, Viberti GC, Keen H, Burt D, Hughes JM, et al. Microalbuminuria and coronary heart disease in NIDDM. Diabetes 1998; 47: 1786-92.
13. Cosson S, Kevorkian JP. Left ventricular diastolic dysfunction: an early sign of diabetic cardiomyopathy ? Diabetes Metab 2003; 29: 455-66.
14. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: An integrated index of vascular function? Circulation 2002; 106: 2085-90.
15. Eren M, Gorgulu S, Uslu N, Celik S, Dagdeviren B, Tezel T. Relation between aortic stiffness and left ventricular diastolic function in patients with hypertension, diabetes, or both. Heart 2004; 90: 37-43.
16. Hamby RI, Zoneraich S, Sherman L. Diabetic cardiomyopathy. JAMA 1974; 229: 1749-54.
17. Meng J, Sakata N, Takebhayashi S, Asano T, Futata T, Araki N, et al. Advanced glycation end pruducts of the Maillard reaction in aortic pepsin-insoluble and pepsin-soluble collagen from diabetic rats. Diabetes 1996; 45: 1037-43.
18. Lino K, Yoshinari M, Yamomoto M, Kaku K, Doi Y, Ichikawa K et al. Effect of glycated collagen on proliferation of human smooth muscle in vitro. Diabetologica 1996; 39: 800-6.
19. Woodman RJ, Watts GF. Measurement and application of arterial stiffness in clinical research: focus on new methodologies and diabetes mellitus. Med Sci Monit 2003; 9: 101-9.
20. Chen ML, Hsu CY. Should the K/DOQI definition of chronic kidney disease be changed? Am J Kidney Dis 2003; 42: 623-5.
21. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2004; 26 (Suppl 1): S5-S20.
22. Pitsavos C, Toutouzas K, Dernellis J, Skoumas J, Skoumbourdis E, Stefanadis C, et al. Aortic stiffness in young patients with heterozygous familial hypercholesterolemia. Am Heart J 1998; 135: 604-8.
23. Stratos C, Stefanadis C, Kallikazaros I, Boudoulas H, Toutouzas P. Ascending aorta distensibility abnormalities in hypertensive patients and response to nifedipine administration. Am J Med 1992; 93: 505-12.
24. Stefanadis C, Stratos C, Boudoulas H, Kourouklis C, Toutouzas P. Distensibility of the ascending aorta: comparison of invasive and non-invasive techniques in healthy men and in men with coronary artery disease. Eur Heart J 1990; 11: 990-6.
25. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-83.
26. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison of necropsy findings. Am J Cardiol 1986; 57: 450-8.
27. de Simone G, Roman MJ, Daniels SR, Devereux RB, Meyer RA, Roman MJ, et al. Left ventricular mass and body size in normotensive children and adults. Assessment of allometric relation and impact of overweight. J Am Coll Cardiol 1992; 20: 1251-60.
28. Gall MA, Roising P, Skott P, Damsbo P, Vaag A, Bech K, et al. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991; 34: 655-61.
29. Yla-Herrtuala S, Sumuvuori H, Karkola K, Mottonen M, Nikkari T. Glycosaminoglycans in normal and atherosclerotic human coronary arteries. Lab Invest 1986; 61: 231-6.
30. Van Hoeven KV, Factor SM. A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. Circulation 1990; 82: 848-55.
31. Hollmann J, Schmidt A, von Bassewitx DB, Buddecke E. Relationship of sulfated glycosaminoglycans and cholesterol content in normal and arteriosclerotic human aorta. Arteriosclerosis 1989; 9: 154-8.
32. Marcum JA, McKenney JB, Rosenberg RD. Acceleration of thrombin-antithrombin complex formation rat hindquarters via heparin-like molecules bound to the endothelium. J Clin Invest 1984; 74: 341-50.
33. Smith A, Karalliedde J, De Angelis L, Goldsmith D and Viberti G. Aortic Pulse Wave Velocity and Albuminuria in Patients with Type 2 Diabetes. J Am Soc Nephrol 2005; 16: 1069-75.
34. Mattix HJ, Hsu CY, Shaykevich S, Curhan G. Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol 2002; 13: 1034-9.
35. American Diabetes Association: Clinical practice recommendations 2001: Diabetic nephropathy. Diabetes Care 2001; 24 (Suppl 1): S69-S72.
36. Tsioufis CP, Lambrou SG, Stefanadis CI, Antoniadis DI, Kallikazaros IE, Pitsavos CE, et al. Albuminuria is associated with abnormal thoracic aortic mechanics in essential hypertension. Am J Cardiol 2000; 86: 797-801.
37. Mule G, Cottone S, Vadala A, Volpe V, Mezzatesta G, Mongiovi R, et al. Relationship between albumin excretion rate and aortic stiffness in untreated essential hypertensive patients. J Intern Med 2004, 256: 22-9.
38. Liu JE, Robbins DC, Palmieri V, Bela JN, Roman MJ, Richard Fabsitz R, et al. Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: The Strong Heart Study. J Am Coll Cardiol 2003; 41: 2022-8.
39. Stefanadis C, Dernellis J, Vlachopoulos C, Tsioufis C, Tsiamis E, Toutauzas K, et al. Aortic function in arterial hypertension determined by pressure-diameter relation: effects of diltiazem. Circulation 1997; 96: 1853-8.
40. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 2001; 38: 932-7.
41. Arnett DK, Boland LL, Evans GW, Riley W, Barnes R, Tyroler HA, et al. Hypertension and arterial stiffness: The Atherosclerosis Risk in Communities Study. ARIC Investigators. Am J Hypertens 2000; 13: 317-23.